chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up at 6:00 AM on Friday 10/29. Was lying on back. Turned to pet dog on my right side slightly. Felt extremely intense vertigo feeling. Came back to center and then rolled to the left to get out bed. Rooms was spinning intensely. Could not walk, had to crawl on floor to summon other family members. Wife took me to Emergency Room. Was able to walk in myself, but holding onto side of building.  It is now Thursday 11/4 and vertigo symptoms are now reduced by 80-90%.
Pt states she had severe pain, lightheaded and a little dizzy. No mention to pharmacist during or after vaccine of ADRs. Pt called today 10/16/2021 states she developed a rash a few days after went to urgent care and was diagnosed with shingles. The rash is under her breast. She was prescribed valacyclovir, gabapentin, prednisone abd ibuprofen
03/20/2021 Vaccination: That evening, I started having a low grade fever; felt horrible. I was achy, my teeth hurt, eye sockets. Mimicked symptoms of first vaccine. Muscle pain was so much worse. 03/20/2021 Took Tylenol. Over the next 2-3 days, those symptoms got better but I started to notice I would get tired. I am a (Privacy) it was getting harder to keep going. Muscle weakness and pain was stronger and lasted longer then the first dose. It was so bad I didn't think I could get up out of my chair some days. **suffered this fog of pain till May/June of 2021; *Muscular Dystrophy;  *COVID 01/2021.
Pain & soreness in arm of injection Muscle pai Shivering Body aches & pains Headache  Tired & weak Diarrhea
I felt perfect before I had flu shots in Clinic.  I started having flu symptoms such as soul throat. headache, muscle ache, short breath, cough, stuffing nose during the night. It has been already one week, still have not recovered yet. My husband had flu shot a month ago at same place, also afterwards had same symptoms as me. I had flu shots in the past years never had such sickness I'm wondering the quality of the flu vaccine.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, chills Narrative:   Other Relevant History:
This spontaneous report was received from a nurse practitioner and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unspecified dates, the patient received improperly stored doses of VARIVAX lot/batch # reported as L028275, expiration date 20-JUL-2017 (dose and route of administration were not reported). No adverse effect reported. Additional information has been requested.
Lathergic the next day (Friday) after shot. Feeling flu-ish by Friday evening?Achy, headache, tired all weekend; my symptoms from my lung problems also seemed to increase. Although it gradual improved a little day by day, I felt like I had the flu for over a week. It is probably important to note that the vaccine shot was approximately 4 1/2 months after I had Covid.
hives started 16 hours after receiving influenza vaccine  Dr. prescribed alternate schedule of Atarax and Benadryl, prednisone(oral & injection)
Flutter in the heart; Heart Rate Increased; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CARDIAC FLUTTER (Flutter in the heart) in a 19-year-old female patient who received mRNA-1273  for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  No Medical History information was reported. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced CARDIAC FLUTTER (Flutter in the heart) (seriousness criterion medically significant) and HEART RATE INCREASED (Heart Rate Increased). On 29-Mar-2021, CARDIAC FLUTTER (Flutter in the heart) and HEART RATE INCREASED (Heart Rate Increased) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Chest X-ray: normal (normal) Normal. On 26-Mar-2021, Electrocardiogram: normal (normal) Normal. On 26-Mar-2021, Heart rate: 106 (abnormal) 106 bpm. On 29-Mar-2021, Heart rate: normal (normal) Normal. The action taken with mRNA-1273 (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided. Reportedly, the patient's second dose is scheduled for 23-Apr-2021.   Reporter did not allow further contact; Sender's Comments: This case concerns a 19-year-old female with a serious unexpected event of cardiac flutter, and nonserious unexpected heart rate. Event onset the same day as first dose mRNA-1273. Events resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Heart Palpitations,   uncontrollable Even Resting in bed,,, heart rate stayed double as normal to 155 and flucuated between 130 - 155  for 2 days. Heart rate would not return to my normal rate of 62-68 BPM for 2 and half days.  ALSO Left arm at injection site, pain and soreness.  ALSO Left underarm to left breast, very sore, swollen lymp areas, left arm pit inflamed, red and swollen.  2 days since shot.. heart rate back to normal, but left arm and left underarm very sore, swollen
REACTIONS STARTED THE SAME DAY AS THE SHOT AND WE ARE ON DAY 6 WITH NO IMPROVEMENT. SEVERE HEAD PAIN, CHILLS, FEVER, WEAKNESS THROUGHOUT ENTIRE BODY, NASEAU, VOMITING (STARTED ON DY 3 LASTING FOR 3 DAYS, THAT SO FAR HAS STOPPED AS OF TODAY 10/7/21), DIARRHEA, NECK PAIN, SHOULDER PAIN, FATIGUE (CAN NOT STAY AWAKE, BUT DOES NOT SLEEP SOUNDLY), DIZZINESS
@ approx 1230PM, pt woke up w/chills & small amount of itching on skin; felt faint & decided to go to ER; states was told it was probably nerves but could be immun; was told BP was very low;
Within 7 days of the injection, my left breast begin to swell and feel uncomfortable. Days after this, left breast nipple inverted. This problem is only escalating in my opinion. Sporadic pain in breast - sharp deep pain. Within 10 days of the injection, large rash appeared at injection site, approx size of a softball. An additional rash also appeared below and to right (towards inner arm) of the injection site; it started small and proceeded to spread to approx several inches. Sporadic pain in upper arm continues. I reported all of this to my physician. I was told to take Tylenol and Bendadryl. I pushed for an appt to check on my breast, and that appt is scheduled for 3/12/21 with a PA.
One week after vaccination my upper arm around injection site started to itch.  Over the next 4 days it grew red, swollen, and increasingly itchy. The patch was approximately 5? x 3?. (I took successive photos which I could share.) Then it began to resolve and was better within a week of onset.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 59-year-old male patient who received SHINGRIX (batch number 77PL3, expiry date 18th April 2021) for prophylaxis. On 13th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced fever, axillary pain and axillary lymph nodes enlarged. On an unknown date, the outcome of the fever, axillary pain and axillary lymph nodes enlarged were recovered/resolved. It was unknown if the reporter considered the fever, axillary pain and axillary lymph nodes enlarged to be related to SHINGRIX. Additional details were reported as follows: After receiving SHINGRIX the patient had a fever for about 3 hours. Within 24 hours of his fever resolving he developed soreness and a swollen lymph node in his armpit. This lasted for about 3 days.
Bilateral Inguinal Adenopathy, Had this reaction with first course of Gardasil vaccine. This was the second vaccine and had same reaction,  Skin in groin area broke out with rash on both sides 2 days after adenopathy noted.
This non-serious initial spontaneous case was received from other health professional on 04-Oct-2017, concerning a 20-year-old, adult, patient of an unspecified gender. The patient's medical history and concomitant medications were not reported. On 04-Oct-2017, the patient was administered with FLUVIRIN THIOMERSAL (dose: 0.5 ml, batch number: 1618621 (as reported), expiry date: Apr-2017, route of administration: intramuscular and anatomical location: deltoid). The patient was administered with expired vaccine and no adverse effect was experienced by the patient. It was reported that, the patient had to revaccinate with current season vaccine. The reporter assessed the event as non-serious. Follow-up received on 12-Oct-2017: The age of the patient was updated. The route of administration of the vaccine and anatomical location were added. Narrative amended accordingly.
Patient comes to ER to report left upper arm redness, pain and swelling to the injection site where she got the covid-19 Moderna vaccine on reported 01/20/21 at the local Pharmacy
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients medical history or concurrent conditions was provided. Since 01-APR-2015 (dates of specific vaccinations not reported), the patients were vaccinated with doses of GARDASIL (strength, dose, frequency, route of administration and injection anatomical location were not reported) (lot # J012212, expiry date 18-FEB-2016; lot # K006124, expiry date 02-FEB-2017; lot # H020901, expiry date 05-JUL-2015; lot # H017698, expiry date 02-JUL-2015) which were exposed to temperature outside of the recommended range since the same day. The reporting nurse was not aware of any adverse effects at the time of this report. This is one of the several reports received from the same source. Additional information has been requested.
Patient received an extra dose of flu vaccine.  She received a dose of Fluzone on 04/23/22 despite having a previous dose on 12/09/21 and her initial 2 dose series during the previous flu season on 03/04/21 and 04/05/21.  This information was not available at the time patient received 04/23/22 dose.
Site: Erythematous, edematous, warm tight area that extends around 80% of the upper half of the left arm below the shoulder. Insertion site of vaccine present above redness. Took: Clindamycin.
EBV was activated; feeling run down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 27Feb2021 (Lot number: EN6203) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (prev dose number: 1, prev dose lot number - L9264), administration date: 06Feb2021, when the patient was 46 years old, for Covid-19 immunization. The following information was reported: EPSTEIN-BARR VIRAEMIA (non-serious) with onset Oct2021, outcome "unknown", described as "EBV was activated"; MALAISE (non-serious) with onset Oct2021, outcome "unknown", described as "feeling run down". The events "ebv was activated" and "feeling run down" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information included: Doctor related that EBV was activated and this could be related to vaccine. The patient had no covid prior vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a other health professional referring to a patient of unknown age and gender. Medical history and current conditions were not reported. On 10-MAR-2016, the patient was orally vaccinated with improperly stored dose of oral, ROTATEQ (dose, frequency and indication w ere not reported; lot # L037924 with expiration date: 22-JUN-2017). Concomitant therapy was not reported. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Starting last Thursday January 28th ,I started to experience shortness of breath at rest. Friday January 29th I was experiencing constant chest tightness/discomfort. Breath started to catch with speaking, fatigue. On Saturday January 30th at work in teh hospital I moved a heavy patient, became short of breath that the patient heard it and inquired about it, and my heart rate went up into the 120s. After a hot shower on January 31st, my heart rate went into the 110s, shortness of breath experienced. Vital signs have all been normal, no fever, normal blood pressure, normal oxygen saturation. My heart rate only increased on Saturday and Sunday and have been fine since. Negative fro Covid on January 29th and Negative for COVID, flu A and B and RSV on Monday February first. Saw to PCP on Wednesday February 3rd and with my symptoms states it is mild myocarditis from the vaccine, to rest and take an NSAID daily for two weeks.
REDNESS, SWELLING, AND ITCHY AT SITE OF VARICELLA IMMUNIZATION.  REPORTS NUMBING ON BOTH FINGERTIPS AND HANDS. ADMINISTERED HYDROCORTISONE 1% CREAM TO APPLY FOR ITCHINESS AND TYLENOL 325MG TABLETS #6 TO BE TAKEN TWO TABLETS EVERY 4-6 HOURS AS NEEDED.
9/28 - Vomited about 1 hour after shots then in evening started with fever - highest 102.4. TYLENOL given which decreased temp, but she still feels warm this morning 9/29. Temp not measured in AM. (Denies rash).
Brain Zaps; This spontaneous case was reported by a patient and describes the occurrence of ELECTRIC SHOCK SENSATION (Brain Zaps) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ELECTRIC SHOCK SENSATION (Brain Zaps). At the time of the report, ELECTRIC SHOCK SENSATION (Brain Zaps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications information was not reported. Treatment information was not provided.
This spontaneous report as received from a pharmacist refers to a 67 year old female patient with no drug reactions/allergies. On 02-OCT-2013 the patient was vaccinated with PNEUMOVAX23 lot # H010515, intramuscular in arm (dosing information was not provided). Concomitant therapies included FLUZONE (same arm, separate site) and unspecified medications. The pharmacist reported that the patient developed an injection site reaction. The patient informed the pharmacist that the patient's arm became sore immediately after the PNEUMOVAX23 vaccination on 02-OCT-2013. And developed into a red, achy, warm to the touch area just below the injection site on 03-OCT-2013. On 04-OCT-2013 the patient went to the physician. ALEVE and ice packs for the swelling were given as treatment. The outcome of the events was reported as not recovered/not resolved. No reporter causality provided. Additional information has been requested.
PATIENT WAS INADVERTINLY GIVEN A MODERNA BIVALENT BOOSTER SHOT TOO EARLY. DUE TO THE VACCINE RECORD. HAVING POORLY WRITTEN VACCINATION DATES. PATIENT WAS NOTIFED ABOUT ERROR. PATIENT WAS UNAFFECTED BY ADDITIONAL DOSE. PATIENT HAD NO COMPLAINTS OR CONCERNS AS A RESULT OF THE ADDITIONAL DOSE.
Immediately after the vaccine was administered, The muscle in my forearm began to twitch and the ring finger and last finger began tingling and neurological reaction.
Extreme tiredness, fever over 103 for 2 days, migraine headache day of and 3 days afterwards. Extreme sweating and chills
Bruising at injection site, knot at injection site and limited range of motion in arm from beginning til patient reported problem on 11/10/2015.
Provider was called to the Vaccine Clinic for possible reaction to find patient with mild labored breathing, diaphoretic and redness to bilateral upper extremities and chest. Patient began feeling SOB, chest tightness, and dizziness reported ~10 minutes following vaccine administration. O2 sat 100% RA, pulse upper 90s to low 100s, BP 120/82. After a few minutes, symptoms unchanged and patient reporting scratchiness to throat starting. Benadryl 50mg given PO, EMS called given worsening SX of SOB and new throat concerns. Patient received J&J x1 Oct 2021, no prior Moderna vaccine before today. Patient denied prior known allergic reactions to vaccines. Paramedics transported patient to ER for further evaluation/monitoring.
pt recv vax & w/in 10 mins of inj pt devel swelling of the face & lips; MD reported 2 pts;
Temp elevation t104 2 days p/shot went to ER was given ATB & told it could be related to cold & shot combo; to be reported to us;
Large swelling extending from elbow to shoulder; Pain in fingers; Pain under the shoulder blade; Red spot at the injection site; Red spot at the injection site developed into large swelling; First dose on 11-Apr-2021 and second dose on 25-Apr-2021; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Large swelling extending from elbow to shoulder), PAIN IN EXTREMITY (Pain in fingers), ARTHRALGIA (Pain under the shoulder blade), VACCINATION SITE ERYTHEMA (Red spot at the injection site) and VACCINATION SITE SWELLING (Red spot at the injection site developed into large swelling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy and Allergy (Allergic to Bandages.).   On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 11-Apr-2021 and second dose on 25-Apr-2021). On an unknown date, the patient experienced PERIPHERAL SWELLING (Large swelling extending from elbow to shoulder), PAIN IN EXTREMITY (Pain in fingers), ARTHRALGIA (Pain under the shoulder blade), VACCINATION SITE ERYTHEMA (Red spot at the injection site) and VACCINATION SITE SWELLING (Red spot at the injection site developed into large swelling). The patient was treated with CORTISONE at a dose of Cortisone regimen. On 25-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 11-Apr-2021 and second dose on 25-Apr-2021) had resolved. At the time of the report, PERIPHERAL SWELLING (Large swelling extending from elbow to shoulder), PAIN IN EXTREMITY (Pain in fingers), ARTHRALGIA (Pain under the shoulder blade), VACCINATION SITE ERYTHEMA (Red spot at the injection site) and VACCINATION SITE SWELLING (Red spot at the injection site developed into large swelling) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) Antibody test for COVID was performed within the 14 days of vaccination shows negative result.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Significant Follow up received: Patient allergies, event outcome, Anatomical location of vaccine given &  treatment information were updated.
Information has been received from a licensed practical nurse concerning a female (age not reported) who on an unspecified date was vaccinated intramuscularly with a 0.5mL first dose of pneumococcal 23v polysaccharide vaccine (lot 657143/0380U). Subsequently, the patient developed arm swelling, shoulder joint pain and immobility in the arm that the injection was given in. The patient called the office to report her experience but was not evaluated in the emergency room. At the time of this report, the patient had not recovered. The nurse requested a lot check be performed on lot 657143/0380U. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center of Biologics Evaluation and Research and was released. The patient's experience was considered disabling due to arm immobility. Additional information has been requested. This is one of two reports from the same source.
fatigue, mild nausea, feeling very cold, body aches beginning 18 hrs post vaccination and lasting about 6-12 hours; arm soreness at injection rate (immediately following injection and lasting  72 hrs)
I have had chronic migraines since early April. I average on about 6 a month. It includes: headaches, lightheadedness, nausea, trouble with vision, fatigue
Tired, fatigued, headache, runny nose, back pain, thirsty, extreme body aches, dizziness, diarrhea
BODY ACHE; DIZZY; CHILLS; HEADACHE; TEMPERATURE GOT AS HIGH AS 101.8; This spontaneous report received from a consumer concerned a 60 year old male. The patient's weight was not reported and height was 170.18 centimeters. The patient's concurrent conditions included alcohol user, non-smoker, and type 2 diabetes mellitus, and other pre-existing medical conditions included the patient had no known allergies to vaccine, drug and food. the patient had no history of drug abuse, no illness at the time of vaccination, no past history of similar events, no adverse event after any previous vaccination, no pre-existing acute illness 30 days prior to vaccination, no history of hospitalization in last 30 days and no family history of any disease (relevant to vaccination) or allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: UNKNOWN) dose was not reported, administered to the right arm, on 08-MAR-2021 06:07 for prophylactic vaccination. Concomitant medications included empagliflozin for type 2 diabetes mellitus, and metformin for type 2 diabetes mellitus. On 08-MAR-2021, the subject experienced body ache. On 08-MAR-2021, the subject experienced dizzy. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced temperature got as high as 101.8. Laboratory data included: Body temperature (NR: not provided) 101.8 deg. On 09-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 99.5 deg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, chills, headache, and temperature got as high as 101.8 on 09-MAR-2021, and had not recovered from dizzy. This report was non-serious.
On 3/20/21 pt started having diarrhea.  Then she started getting chills, body aches, headache, dizziness and nauseated.  Her back and legs are hurting.  She has had these symptoms for over a week.  She has been taking anti-diarrhea meds and Tylenol and Advil.   Pt will contact her PCP.
Fever of 100.3 on and off for 48 hours, violent chills, body aches, nausea, pain at injection site, swelling of lymph nodes in left armpit for several days after injection
Five days, post vax, child became febrile. Seen at hospital. On 4/24/01, after septic work-up; LP and blood cultures, child was discharged on 4/26/01. Dx'd with ? viral illness. Child discharge shows viral illness/fever.
Client reports 1-2 hrs post receiving hep B that her stomach started hurting. States she started having dizziness and blurred vision with vomiting and hot flashes around pm. States she took Pepto-Bismol and Advil that night. The following day she states she continued to have vomiting, headache and stomach ache. Reports she had these same symptoms with previous Hep B but thought she had a virus and did not report.